Moreover, under disease conditions such as obesity and diabetes, GSK3β-mediated MG53 phosphorylation is robustly enhanced, resulting in markedly diminished IR and IRS1 levels in the heart and skeletal muscle and exaggerated systemic insulin resistance (see below for further discussion). This evidence concerns the gene GSK3B and diabetes mellitus.